SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?


To: Laurens who wrote (81)3/9/1998 7:26:00 PM
From: WTDEC  Respond to of 1834
 
Good evening Laurens.

I was preparing a follow-up note to you but noticed this posting today. It turns out that about a month ago I put NBIX on a short list of companies I like, but don't already own. Amazing coincidence!

I think the points you make are good ones. The top management, unlike many young biotechs, comes with deep experience at major pharmas and the Board includes David Robinson from LGND.

I'll be trying to do more research on NBIX and I'll let you know what I find out. Also, I'll be sending you a note in the near future on the other topics we discussed.

Regards,

Walter



To: Laurens who wrote (81)3/12/1998 1:07:00 PM
From: Patrick grogan  Read Replies (1) | Respond to of 1834
 
NEUROCRINE TO ACQUIRE NORTHWEST NEUROLOGIC FOR
$4.2M IN STOCK

By Vicki Brower
Special to BioWorld Today

Neurocrine Biosciences Inc. signed an agreement to acquire
privately held Northwest Neurologic Inc. (NNL), for $4.2 million in
stock.

This appeared in BioWorld yesterday(it's a biotech newsletter). I haven't seen it anywhere else, can anybody substantiate/comment.